Baseline characteristics of patients included in the study
| Phase 1, N (%) | Phase 2, N (%) | p Value | |
| Positive rectal NAAT | 106 | 159 | |
| Treated as per protocol | 89 (84) | 78 (49) | <0.0001 |
| Gender | 0.2146 | ||
| Male | 46 (51.7) | 48 (61.5) | |
| Female | 43 (48.3) | 30 (38.5) | |
| Symptomatic | 1 (1.1) | 4 (5.1) | 0.1860 |
| Male | 1* (2.2) | 4† (8.3) | |
| Female | 0 (0) | 0 (0) | |
| L venereum isolated | 0 | 1 | 0.4671 |
| C trachomatis positive at another site | 26 | 22 | 1.0000 |
| Male | 1 | 4 | |
| Female‡ | 25 | 18 | |
| Known HIV positive | 3 | 3 | 1.0000 |
| Concomitant STI | 17 | 17 | 0.7032 |
| HIV | 0 | 0 | |
| Syphilis | 3 | 0 | |
| Hepatitis B | 1 | 0 | |
| Herpes simplex virus | 2 | 1 | |
| Gonorrhoea | 4 | 7 | |
| Anogenital warts | 4 | 6 |
↵* One male patient presented with rectal symptoms and had concurrent rectal gonorrhoea.
↵† Of the four men who reported rectal symptoms, one had confirmed L venereum and two had concurrent rectal gonorrhoea.
↵‡ Women were statistically more likely than men to have C trachomatis isolated from a concurrent site (p<0.0001).
NAAT, nucleic acid amplification test, STI, sexually transmitted infection.